drugset / Trial / NCT05821075

Efficacy of Prednisolone Versus Cerebrolysin in the Treatment of Bell's Palsy

NCT05821075

Phase 1/2 Recruiting 90 enrolled October 6 University
RandomizedParallel-groupDouble-blindTreatment

Summary

Bell's palsy, a peripheral facial nerve paresis, is the most common disorder of the facial nerve and one of the most common mononeuropathies. Many patients with Bell's palsy will develop some complications such as synkinesis, crocodile tears and 'sweating' of the ear while eating Commonly used medications to treat Bell's palsy is Corticosteroids Cerebrolysin stimulates the regeneration of the nervous tissue with protective action we aim to study the efficacy of cerebrolycin in Bell's palsy

Timeline

Start
2023-08-24
Primary completion
2026-01
Completion
2026-02

Drugs

EvaluationDrugModalityDoseRoute
Comparator Cerebrolysin Peptide 10 mg Intramuscular
Comparator Prednisolone Other / unclassified 60 mg

Indications